Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Franz Messerli

Showing results (1-10 of 22) with videos related to

Pageof 3
Sort By:
The American Journal of Cardiology|May 29, 2007
Alcohol-induced hypertension--just how much of a cardiovascular risk factor?Aslam Khan, Franz Messerli
Journal of Clinical Hypertension (Greenwich, Conn.)|September 17, 2013
Effect of allopurinol on blood pressure (author response to Allopurinol on hypertension: insufficient evidence to recommend)Vikram Agarwal, Franz Messerli
The New England Journal of Medicine|April 30, 2015
Surgical treatment of moderate ischemic mitral regurgitationEdgar Argulian, Franz Messerli
The American Journal of Medicine|July 30, 2013
Misconceptions and facts about pericardial effusion and tamponadeEdgar Argulian, Franz Messerli
Cleveland Clinic Journal of Medicine|January 29, 2020
Is diabetes still a compelling indication for renin-angiotensin-aldosterone system inhibitors?Robert Fakheri, Sripal Bangalore, Franz Messerli
European Heart Journal|May 5, 2016
Teachable moment or missed opportunity?Franz Messerli, Sripal Bangalore, Bernhard Meier
Journal of Clinical Hypertension (Greenwich, Conn.)|October 18, 2005
Hypertension: definitions and guidelinesJohn B Kostis, Franz Messerli, Thomas D Giles
Progress in Cardiovascular Diseases|November 18, 2009
Flash pulmonary edemaStefano F Rimoldi, Melana Yuzefpolskaya, Yves Allemann, et al.
American Journal of Therapeutics|November 9, 2002
Chrono: a community-based hypertension trial of a chronotherapeutic formulation of verapamilL Michael Prisant, Henry R Black, Franz Messerli, et al.
Deutsche Medizinische Wochenschrift (1946)|April 24, 2020
[Renin-Angiotensin-System (RAS) and COVID-19 - On The Prescription of RAS Blockers]Reinhold Kreutz, Engi Abd El-Hady Algharably, Detlev Ganten, et al.
Pageof 3

Showing results (1-10 of 22) with videos related to

Sort By:
Pageof 3
The American Journal of Cardiology|May 29, 2007
Alcohol-induced hypertension--just how much of a cardiovascular risk factor?Aslam Khan, Franz Messerli
Journal of Clinical Hypertension (Greenwich, Conn.)|September 17, 2013
Effect of allopurinol on blood pressure (author response to Allopurinol on hypertension: insufficient evidence to recommend)Vikram Agarwal, Franz Messerli
The New England Journal of Medicine|April 30, 2015
Surgical treatment of moderate ischemic mitral regurgitationEdgar Argulian, Franz Messerli
The American Journal of Medicine|July 30, 2013
Misconceptions and facts about pericardial effusion and tamponadeEdgar Argulian, Franz Messerli
Cleveland Clinic Journal of Medicine|January 29, 2020
Is diabetes still a compelling indication for renin-angiotensin-aldosterone system inhibitors?Robert Fakheri, Sripal Bangalore, Franz Messerli
European Heart Journal|May 5, 2016
Teachable moment or missed opportunity?Franz Messerli, Sripal Bangalore, Bernhard Meier
Journal of Clinical Hypertension (Greenwich, Conn.)|October 18, 2005
Hypertension: definitions and guidelinesJohn B Kostis, Franz Messerli, Thomas D Giles
Progress in Cardiovascular Diseases|November 18, 2009
Flash pulmonary edemaStefano F Rimoldi, Melana Yuzefpolskaya, Yves Allemann, et al.
American Journal of Therapeutics|November 9, 2002
Chrono: a community-based hypertension trial of a chronotherapeutic formulation of verapamilL Michael Prisant, Henry R Black, Franz Messerli, et al.
Deutsche Medizinische Wochenschrift (1946)|April 24, 2020
[Renin-Angiotensin-System (RAS) and COVID-19 - On The Prescription of RAS Blockers]Reinhold Kreutz, Engi Abd El-Hady Algharably, Detlev Ganten, et al.
Pageof 3